Joshua D. Thomas

A Polymer-Based Antibody–Vinca Drug Conjugate Platform: Characterization and Preclinical Efficacy

Alexander V. Yurkovetskiy, Mao Yin, Natalya D. Bodyak et al. · Cancer Research · 2015 · 100 citations

Pharmacy, Oncology, Pharmacology +17

Dolaflexin: A Novel Antibody–Drug Conjugate Platform Featuring High Drug Loading and a Controlled Bystander Effect

Aleksandr V. Yurkovetskiy, Natalya D. Bodyak, Mao Yin et al. · Molecular Cancer Therapeutics · 2021 · 75 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Discovery and Optimization of a STING Agonist Platform for Application in Antibody Drug Conjugates

Jeremy R. Duvall, Joshua D. Thomas, Raghida A. Bukhalid et al. · Journal of Medicinal Chemistry · 2023 · 52 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +17

Tumor Necrosis Factor (TNF) Receptor Superfamily Member 1b on CD8⁺T Cells and TNF Receptor Superfamily Member 1a on Non-CD8⁺T Cells Contribute Significantly to Upper Genital Tract Pathology Following Chlamydial Infection

Srikanth Manam, Joshua D. Thomas, Weidang Li et al. · The Journal of Infectious Diseases · 2014 · 37 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +16

XMT-2056, a HER2-Directed STING Agonist Antibody–Drug Conjugate, Induces Innate Antitumor Immune Responses by Acting on Cancer Cells and Tumor-Resident Immune Cells

Raghida A. Bukhalid, Jeremy R. Duvall, Kelly L. Lancaster et al. · Clinical Cancer Research · 2025 · 36 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17